Efficacy and safety of a single-use cholangioscope for percutaneous transhepatic cholangioscopy
Endoscopy International Open · 01.08.2024 · 12 (08) · E981-E988
DOI: 10.1055/a-2366-2265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.08.2024. Verfasst von Ivo Boskoski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boston Scientific Corporation.
Abstract (Originalsprache)
Background and study aims Percutaneous transhepatic cholangioscopy (PTCS) is a management option for patients in whom peroral cholangioscopy or endoscopic retrograde cholangiopancreatography (ERCP) fail. We conducted a case series on the efficacy and safety of PTCS using a cholangiopancreatoscope cleared by the US Food and Drug Administration in 2020. Patients and methods Fifty adult patients scheduled for PTCS or other cholangioscopic procedure were enrolled at seven academic medical centers and followed for 30 days after the index procedure. The primary efficacy endpoint was achievement of clinical intent by 30 days after the index PTCS procedure. Secondary endpoints included technical success, procedure time, endoscopist ratings of device attributes on a scale of 1 to 10 (best), and serious adverse events (SAEs) related to the device or procedure.
Results
Patients had a mean age of 64.7±15.9 years, and 60.0% (30/50) were male. Forty-four patients (88.0%) achieved clinical intent by 30 days post-procedure. The most common reasons for the percutaneous approach were past (38.0%) or anticipated (30.0%) failed ERCP. The technical success rate was 96.0% (48/50), with a mean procedure time of 37.6 minutes (SD, 25.1; range 5.0–125.0). The endoscopist rated the overall ability of the cholangioscope to complete the procedure as a mean 9.2 (SD, 1.6; range 1.0–10.0). Two patients (4.0%) experienced related SAEs, one of whom had a fatal periprocedure aspiration.
Conclusions
PTCS is an important endoscopic option for selected patients with impossible retrograde access or in whom ERCP fails. Because of the associated risk, this technique should be practiced by highly trained endoscopists at high-volume centers. (ClinicalTrials.gov number, NCT04580940)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany.
- Surgery, The Chinese University of Hong Kong, New Territories, Hong Kong.
- Gastroenterology and Hepatology, Hôpital Erasme, Bruxelles, Belgium.
- Radiology, Virginia Mason Medical Center, Seattle, United States.
- Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
ORCID-Profile: Ivo Boskoski, Arnaud Lemmers
Förderung
- Boston Scientific Corporation
Zitieren
APA
Boskoski, I., Beyna, T., Lau, J. Y., Lemmers, A., Fotoohi, M., Ramchandani, M., Pontecorvi, V., Peetermans, J., & Shlomovitz, E. (2024). Efficacy and safety of a single-use cholangioscope for percutaneous transhepatic cholangioscopy. Endoscopy International Open, 12(08), E981-E988. https://doi.org/10.1055/a-2366-2265
Vancouver
Boskoski I, Beyna T, Lau JY, Lemmers A, Fotoohi M, Ramchandani M, et al. Efficacy and safety of a single-use cholangioscope for percutaneous transhepatic cholangioscopy. Endoscopy International Open. 2024;12(08):E981-E988. doi:10.1055/a-2366-2265
BibTeX
@article{Boskoski2024,
author = {Boskoski, Ivo and Beyna, Torsten and Lau, James Yw and Lemmers, Arnaud and Fotoohi, Mehran and Ramchandani, Mohan and Pontecorvi, Valerio and Peetermans, Joyce and Shlomovitz, Eran},
title = {Efficacy and safety of a single-use cholangioscope for percutaneous transhepatic cholangioscopy},
journal = {Endoscopy International Open},
year = {2024},
volume = {12},
number = {08},
pages = {E981--E988},
doi = {10.1055/a-2366-2265}
}
EUVIMED